Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) – a prospective, randomized, 2-armed phase-II-trial

Overview of attention for article published in BMC Cancer, January 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 6,435 followers.

RT @pierfra22138137: @NiuSanford @IanJPereira @DrN_CancerPCP @subatomicdoc @ASTRO_org @JenniferWo4 @JonAshmanMD @AnnRaldow_MD @MontefioreD…

Reply Repost Favourite

@NiuSanford @IanJPereira @DrN_CancerPCP @subatomicdoc @ASTRO_org @JenniferWo4 @JonAshmanMD @AnnRaldow_MD @MontefioreD @fireflyann @ARosen380 @ng_kimmie @ebludmir @DrVMisra @DrKrisDennis @HinaSaeedMD @fumikochino There is a nice trial going on in Heidelberg

Reply Repost Favourite

RT @radoncpapers: Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) - a prospective, randomi…

Reply Repost Favourite

Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) - a prospective, randomized, 2-armed phase-II-trial. https://t.co/quSC6wncS3 h/t @NCBI #RadOnc #PubMed

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.